BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 30082680)

  • 1. Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis.
    Buccarelli M; Marconi M; Pacioni S; De Pascalis I; D'Alessandris QG; Martini M; Ascione B; Malorni W; Larocca LM; Pallini R; Ricci-Vitiani L; Matarrese P
    Cell Death Dis; 2018 Aug; 9(8):841. PubMed ID: 30082680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
    Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cyclin E1 overcomes temozolomide resistance in glioblastoma by Mcl-1 degradation.
    Liang H; Chen Z; Sun L
    Mol Carcinog; 2019 Aug; 58(8):1502-1511. PubMed ID: 31045274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells.
    Zhao K; Schäfer A; Zhang Z; Elsässer K; Culmsee C; Zhong L; Pagenstecher A; Nimsky C; Bartsch JW
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.
    Huang T; Wan X; Alvarez AA; James CD; Song X; Yang Y; Sastry N; Nakano I; Sulman EP; Hu B; Cheng SY
    Autophagy; 2019 Jun; 15(6):1100-1111. PubMed ID: 30654687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
    Garnier D; Meehan B; Kislinger T; Daniel P; Sinha A; Abdulkarim B; Nakano I; Rak J
    Neuro Oncol; 2018 Jan; 20(2):236-248. PubMed ID: 29016925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide.
    Xu X; Zheng Y; Luo L; You Z; Chen H; Wang J; Zhang F; Liu Y; Ke Y
    Cell Death Dis; 2024 May; 15(5):318. PubMed ID: 38710703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells.
    Noh H; Zhao Q; Yan J; Kong LY; Gabrusiewicz K; Hong S; Xia X; Heimberger AB; Li S
    Cancer Lett; 2018 Oct; 433():176-185. PubMed ID: 29991446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme-Role in Pathogenesis and Therapeutic Perspective.
    Pawlowska E; Szczepanska J; Szatkowska M; Blasiak J
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicardipine sensitizes temozolomide by inhibiting autophagy and promoting cell apoptosis in glioma stem cells.
    Shi J; Dong X; Li H; Wang H; Jiang Q; Liu L; Wang L; Dong J
    Aging (Albany NY); 2021 Feb; 13(5):6820-6831. PubMed ID: 33621205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells.
    Zhu Z; Zhang P; Li N; Kiang KMY; Cheng SY; Wong VK; Leung GK
    Biomed Res Int; 2019; 2019():2710693. PubMed ID: 31662972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest.
    Yu Q; Liu L; Wang P; Yao Y; Xue Y; Liu Y
    Cell Cycle; 2017 Jun; 16(11):1085-1092. PubMed ID: 28436750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.
    MacLeod G; Bozek DA; Rajakulendran N; Monteiro V; Ahmadi M; Steinhart Z; Kushida MM; Yu H; Coutinho FJ; Cavalli FMG; Restall I; Hao X; Hart T; Luchman HA; Weiss S; Dirks PB; Angers S
    Cell Rep; 2019 Apr; 27(3):971-986.e9. PubMed ID: 30995489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition.
    Liu T; Li A; Xu Y; Xin Y
    Oncol Rep; 2019 Mar; 41(3):1883-1892. PubMed ID: 30664175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response.
    Hombach-Klonisch S; Mehrpour M; Shojaei S; Harlos C; Pitz M; Hamai A; Siemianowicz K; Likus W; Wiechec E; Toyota BD; Hoshyar R; Seyfoori A; Sepehri Z; Ande SR; Khadem F; Akbari M; Gorman AM; Samali A; Klonisch T; Ghavami S
    Pharmacol Ther; 2018 Apr; 184():13-41. PubMed ID: 29080702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.
    Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH
    Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma.
    Kitabayashi T; Dong Y; Furuta T; Sabit H; Jiapaer S; Zhang J; Zhang G; Hayashi Y; Kobayashi M; Domoto T; Minamoto T; Hirao A; Nakada M
    Sci Rep; 2019 Jul; 9(1):10049. PubMed ID: 31296906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.
    Balvers RK; Lamfers ML; Kloezeman JJ; Kleijn A; Berghauser Pont LM; Dirven CM; Leenstra S
    J Transl Med; 2015 Feb; 13():74. PubMed ID: 25886061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.
    D'Alimonte I; Nargi E; Zuccarini M; Lanuti P; Di Iorio P; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Ciccarelli R
    Purinergic Signal; 2015 Sep; 11(3):331-46. PubMed ID: 25976165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.